PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Comprehensive Review

Volume 7 Issue 3

A Comprehensive Review of Modified release dosage forms and its Formulation Approaches, In-Vitro Characterizations, and Pharmaceutical Applications

R Nepolean, K Chandramohan, K Rajkumar*, D Anbarasu and S Sivasankari

March 02, 2026

DOI : 10.56831/PSSRP-07-252

Abstract

Modified release dosage forms are designed in order to control the release of the drug, optimize the pharmacokinetic profiles and the adherence of patients in comparison to conventional immediate release systems. This review defines the historical evolution, categorization and formulation strategies of these technologies ranging from hydrophilic and hydrophobic matrix systems to reservoir based designs, osmotic mechanisms and gastroretentive approaches. It focuses on how the polymer properties, solubility of the drug and the kinetic pathway affect the controlled release of therapeutics. In vitro evaluation methodologies such as dissolution profiling in biorelevant media, mathematical modelling, swelling erosion assessment, morphological characterization and stability evaluation are discussed to demonstrate the use of such methodologies to predict in vivo performance. Pharmaceutical application, throughout chronic disease management and site specific delivery, emphasizes the therapeutic benefit of MR systems in the long lasting plasma concentration, decreasing the number of administrations as well as ensuring safety. Emerging trends such as smart responsive materials, AI assisted formulation design and 3D printing are presented as future directions for personalized modified release dosage therapies.

Keywords: Modified release dosage forms; Matrix technology; Osmotic delivery; Gastroretentive systems; controlled drug release

References

  1. M Chountoulesi, C Demetzos and M Vlachou. “Modified-release drug delivery systems with emphasis on oral dosage forms” (2024).
  2. SJ Trenfield and AW Basit. “Modified drug release: Current strategies and novel technologies for oral drug delivery”. Elsevier eBooks (2020).
  3. K Adibkia., et al. “Gastro Retentive Drug Delivery Systems: A Review” (2013).
  4. A Ainurofiq., et al. “Chitosan as floating-mucoadhesive polymers in gastroretentive drug delivery”. Science, Engineering and Health Studies (2023).
  5. A Alzahrani., et al. “A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation”. International journal of pharmaceutics (2022).
  6. D Arora., et al. “A Brief Review on Floating Drug Delivery System”. Journal of Drug Delivery and Therapeutics (2021).
  7. A Awad, SJ Trenfield and AW Basit. “Solid oral dosage forms”. Elsevier eBooks (2021).
  8. S Baghel, H Cathcart and NJ O’Reilly. “Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs”. Journal of Pharmaceutical Sciences (2016).
  9. J Becelaere., et al. “Stable amorphous solid dispersion of flubendazole with high loading via electrospinning”. Journal of Controlled Release (2022).
  10. P Bhatt., et al. “Oral Controlled Release Systems: Current Strategies and Challenges”. Springer eBooks (2019).
  11. SV Bhujbal., et al. “Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies”. Acta Pharmaceutica Sinica B (2021).
  12. H Dalvadi and JK Patel. “Chronpharmaceutics, pulsatile drug delivery system as current trend” (2010).
  13. S Das, S Kaur and V Kumar. “Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery”. Drug Delivery and Translational Research (2021).
  14. A Dashevskiy., et al. “Micropellets coated with Kollicoat® Smartseal 30D for taste masking in liquid oral dosage forms”. Drug development and industrial pharmacy (2017).
  15. S Dey and P Saha‐Chaudhuri. “Floating Drug Delivery System” (2013).
  16. AA Dingalwar. “Polyelectrolyte Complex-based Multiparticulate Drug Delivery System: A Special Emphasis on Chitosan and Alginate”. Asian Journal of Pharmaceutics (2024).
  17. P Drapińska., et al. “Sustained-Release Oral Delivery of NSAIDs and Acetaminophen: Advances and Recent Formulation Strategies—A Systematic Review”. Pharmaceutics (2025).
  18. A Dubey., et al. “Advancements and Challenges in Gastroretentive Drug Delivery Systems: A Comprehensive Review of Research Innovation, Technologies, and Clinical Applications”. Recent Advances in Drug Delivery and Formulation (2025).
  19. S Gad, E Heikal and T Hamadi. “Bioadhesive Drug Delivery Systems: A Review”. Records of Pharmaceutical and Biomedical Sciences (2023).
  20. P Gadziński., et al. “Ionotropic Gelation and Chemical Crosslinking as Methods for Fabrication of Modified-Release Gellan Gum-Based Drug Delivery Systems”. Pharmaceutics (2022).
  21. PK Gaur., et al. “Ion Exchange Resins in Gastroretentive Drug Delivery: Characteristics, Selection, Formulation and Applications”. Journal of pharmaceutical sciences and pharmacology (2014).
  22. S Gupta, P Benien and PK Sahoo. “Ion Exchange Resins Transforming Drug Delivery Systems”. Current drug delivery (2010).
  23. T Hussain. “Formulation development of mucoadhesive drug delivery system for milnacipran HCL using design of experiment approach” (2019).
  24. SV Khairnar., et al. “Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles”. Pharmaceutics (2022).
  25. J Li., et al. “Preparation of Azithromycin Amorphous Solid Dispersion by Hot-Melt Extrusion: An Advantageous Technology with Taste Masking and Solubilization Effects”. Polymers (2022).
  26. V Kumar, S Somkuwar and AK Singhai. “A recent update on gastro retentive drug delivery systems”. GSC Biological and Pharmaceutical Sciences (2024).
  27. R Khan. “Gastroretentive Drug Delivery System - A Review”. International journal of pharma and bio sciences (2013).
  28. SRT Mahmood and S Rousheen. “Pulsatile Drug Delivery System- A Review” (2021).
  29. Nithyashree., et al. “Floating Microballoon – A Novel Formulation for Gastrointestinal Diseases” (2020).
  30. D Nyavanandi., et al. “Impact of hydrophilic binders on stability of lipid-based sustained release matrices of quetiapine fumarate by the continuous twin screw melt granulation technique”. Advanced Powder Technology (2021).
  31. J Pandit, SK Singh and M Muthu. “Controlled release formulations in neurology practice” (2006).
  32. K Patel, S Shah and J Patel. “Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review”. DARU Journal of Pharmaceutical Sciences (2022).
  33. VK Pawar., et al. “Industrial perspective of gastroretentive drug delivery systems: Physicochemical, biopharmaceutical, technological and regulatory consideration”. Expert opinion on drug delivery (2012).
  34. A Porwal, H Dwivedi and K Pathak. “Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy” (2017).
  35. S Poudel and DW Kim. “Developing pH-Modulated Spray Dried Amorphous Solid Dispersion of Candesartan Cilexetil with Enhanced In Vitro and In Vivo Performance”. Pharmaceutics (2021).
  36. JA Prathap. Journal of Population Therapeutics & Clinical Pharmacology (2023).
  37. A Pund., et al. “Recent Patents on Modified Release Oral Dosage Forms”. Journal of Drug Delivery and Therapeutics (2021).
  38. RS Solunke. “Pulsatile Drug Delivery System: A Review”. International Journal for Research in Applied Science and Engineering Technology (2023).
  39. P Salunke., et al. “Floating Drug Delivery System: An Approach to Gastro Retention” (2014).
  40. J Stephin, M Koland and K Marina. “Preparation and Investigation of Gastro-Retentive Mucoadhesive Microspheres of Clarithromycin-Resin Complex” (2020).
  41. E Szabó., et al. “Comparison of Amorphous Solid Dispersions of Spironolactone Prepared by Spray Drying and Electrospinning: The Influence of the Preparation Method on the Dissolution Properties”. Molecular Pharmaceutics (2021).
  42. S Tambe., et al. “Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization”. Pharmaceutics (2022).
  43. J Tripathi., et al. “Current State and Future Perspectives on Gastroretentive Drug Delivery Systems”. Pharmaceutics (2019).
  44. PL Trần., et al. “Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs”. Pharmaceutics (2019).
  45. I-R Turac., et al. “Expanding the Manufacturing Approaches for Gastroretentive Drug Delivery Systems with 3D Printing Technology”. Pharmaceutics (2024).
  46. T Vasconcelos., et al. “Amorphous solid dispersions: Rational selection of a manufacturing process”. Advanced Drug Delivery Reviews (2016).
  47. MA Waqar., et al. “Advanced polymers and recent advancements on gastroretentive drug delivery system; a comprehensive review”. Journal of drug targeting (Print) (2024).
  48. F Zahid., et al. “Controlled Release Drug Delivery System Via Electrospraying and Electrospinning”. CRC Press eBooks (2025).
  49. Gunjan Gadge., et al. “Current Approaches on Gastro Retentive Drug Delivery System: An Overview”. International Journal of Pharmacy Research & Technology (2019).